Skip to main content
Terug
CBT logo

Cabot Corporation

Datakwaliteit: 100%
CBT
NYSE Basic Materials Chemicals - Specialty
€ 70,71
▲ € 2,25 (3,29%)
Marktkapitalisatie: 3,69B
Dagbereik
€ 67,65 € 70,95
52-Weeksbereik
€ 58,33 € 84,54
Volume
360.138
50D / 200D Gem.
€ 72,82 / € 72,63
Vorige Slotkoers
€ 68,46

Koershistorie

Financiële Trends

Sectorvergelijking

vs Basic Materials sector mediaan (467 peers)

Metriek Aandeel Sector Mediaan
P/E 11,2 2,3
P/B 2,4 1,7
ROE % 22,3 5,9
Net Margin % 8,9 5,3
Rev Growth 5Y % 2,2 4,8
D/E 0,8 0,4

Koersdoel Analisten

Hold
€ 78,00 +10.3%
Low: € 74,00 High: € 85,00
Forward K/W
11,0
Forward WPA
€ 6,23
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,5 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2029 € 8,70
€ 8,51 – € 8,92
 4,1 B 1
FY2028 € 7,54
€ 7,37 – € 7,73
 3,8 B 2
FY2027 € 6,86
€ 6,74 – € 6,94
 3,6 B 4

Belangrijkste Punten

Revenue grew 2,16% annually over 5 years — modest growth
Earnings declined -12,89% over the past year
ROE of 22,25% indicates high profitability
Generating 391,00M in free cash flow
P/E of 11,16 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,20%

Groei

Revenue Growth (5Y)
2,16%
Revenue (1Y)-7,04%
Earnings (1Y)-12,89%
FCF Growth (3Y)5,54%

Kwaliteit

Return on Equity
22,25%
ROIC16,84%
Net Margin8,91%
Op. Margin16,73%

Veiligheid

Debt / Equity
0,78
Current Ratio1,61
Interest Coverage8,17

Waardering

P/E Ratio
11,16
P/B Ratio2,38
EV/EBITDA7,49
Dividend Yield0,02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -7,04% Revenue Growth (3Y) -2,81%
Earnings Growth (1Y) -12,89% Earnings Growth (3Y) -13,75%
Revenue Growth (5Y) 2,16% Earnings Growth (5Y) 7,27%
Profitability
Revenue (TTM) 3,71B Net Income (TTM) 331,00M
ROE 22,25% ROA 8,68%
Gross Margin 25,32% Operating Margin 16,73%
Net Margin 8,91% Free Cash Flow (TTM) 391,00M
ROIC 16,84% FCF Growth (3Y) 5,54%
Safety
Debt / Equity 0,78 Current Ratio 1,61
Interest Coverage 8,17 Dividend Yield 0,02%
Valuation
P/E Ratio 11,16 P/B Ratio 2,38
P/S Ratio 0,99 PEG Ratio -1,16
EV/EBITDA 7,49 Dividend Yield 0,02%
Market Cap 3,69B Enterprise Value 4,65B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3,71B 3,99B 3,93B 4,32B 3,41B
Net Income 331,00M 380,00M 445,00M 209,00M 250,00M
EPS (Diluted) 6,02 6,72 7,73 3,62 4,34
Gross Profit 940,00M 960,00M 839,00M 885,00M 799,00M
Operating Income 621,00M 614,00M 526,00M 389,00M 454,00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3,82B 3,74B 3,60B 3,53B 3,31B
Total Liabilities 2,11B 2,15B 2,20B 2,49B 2,22B
Shareholders' Equity 1,55B 1,43B 1,26B 898,00M 947,00M
Total Debt 1,22B 1,33B 1,36B 1,53B 1,25B
Cash & Equivalents 258,00M 223,00M 238,00M 206,00M 168,00M
Current Assets 1,54B 1,61B 1,63B 1,82B 1,43B
Current Liabilities 957,00M 772,00M 822,00M 1,11B 1,15B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Contrarian Investing (David Dreman)
#468 of 670
16

Recente Activiteit

Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026